NCT03890991

Brief Summary

In Singapore, the prevalence of diabetes was approximately 12.8% in 2014 and was projected to rise to 22.7% in 2035. In 2015, the International Diabetes Federation (IDF) reported that Singapore has the second highest proportion of diabetic patients among developed nations. The impact of poorly controlled diabetes on the individual, family and health system is well known. Previous studies have shown that older persons, specifically those with chronic conditions such as diabetes, often lack sufficient knowledge about their condition and thus frequently have poor self-management skills, which is essential for good health outcome. Health education among older persons, particularly those with chronic illnesses, has long been promoted as a priority. Chodosh and colleagues (2005) determined that there were benefits and significant improvement in blood glucose and blood pressure for chronic disease self-management programs for older adults with diabetes and high blood pressure respectively in a meta-analysis study. This project \[Self-Care for Older People with Diabetes Mellitus (SCOPE-DM)\] was therefore developed to help community-dwelling older patients with type 2 diabetes to effectively manage their disease by reducing diabetes-related risk factors and complications, leading to an improvement in their psychological well-being and health-related quality of life, as well as a reduction in future healthcare requirements from family and society. This study aims to investigate the effectiveness of the SCOPE-DM programme in improving the self-efficacy, motivation, medication adherence, health-related quality of life and diabetes knowledge among community-dwelling older adults with type 2 diabetes in Singapore. This proposed study is a prospective, four-group cluster randomized controlled trial. The participants will be followed up for 6 months at the community sites and Hua Mei Clinics of the Tsao Foundation. A set of questionnaires will be used to assess participants' self-efficacy, diabetic self-care activities, health-related quality of life (HRQoL), diabetes knowledge and medication adherence. Process evaluation will also be conducted to assess the acceptability, strengths and weaknesses of the 'SCOPE-DM: Live Well with Diabetes' programme based on the participants' perspectives through the conduct of qualitative interviews.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
320

participants targeted

Target at P75+ for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Feb 2019

Longer than P75 for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 26, 2019

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

March 14, 2019

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 26, 2019

Completed
5.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

September 28, 2022

Status Verified

September 1, 2022

Enrollment Period

5.8 years

First QC Date

March 14, 2019

Last Update Submit

September 27, 2022

Conditions

Keywords

InterventionSelf-efficacyDiabetes Self-care ActivitiesSelf-Monitoring of Blood GlucoseDiabetesCommunityOlder people with diabetes

Outcome Measures

Primary Outcomes (2)

  • Self-efficacy assessed using the General Self-efficacy Scale

    Participants' level of self-efficacy is assessed using the ten-item General Self-efficacy Scale. Participants indicate their responses on a Likert scale of 1 ("Not at all true") to 4 ("Exactly true"). Scores for the ten items are then summed, with higher summed scores indicating higher levels of self-efficacy. The minimum possible summed score is 10 and the maximum possible summed score is 40. Participants in the three intervention conditions are hypothesized to have statistically significantly higher summed scores post-intervention, compared to control condition participants.

    6 months

  • Diabetes self-care activities measured using the Revised Summary of Diabetes Self-care Activities

    Diabetes self-care activities are assessed using a 13-item scale. Participants indicate their responses to items 1 to 12 on a scale of 0 to 7 corresponding to the number of days within the past seven days that they have performed the activities indicated. For item 13, participants indicate whether they have smoked within the past seven days, and if so, how many cigarettes on an average day. For each regimen area of general diet, exercise, blood sugar testing, footcare, and medications, the responses of the corresponding items are averaged to indicate the mean number of days, with a higher value indicating a higher level of self-care activity for the regimen area. A score of 0 is assigned to non-smoking and a score of 1 assigned to smoking, with higher scores indicating lower self-care. Participants in the three intervention conditions are hypothesized to have a statistically significantly higher level of self-care activities post-intervention, compared to control participants.

    6 months

Secondary Outcomes (8)

  • Diabetes-specific quality of life measured using the Audit of Diabetes-Dependent Quality of Life

    6 months

  • Participants' level of knowledge of Diabetes assessed using the Revised Michigan Diabetes Knowledge Questionnaire

    6 months

  • Participants' level of medication adherence assessed using Medication Adherence Report Scale

    6 months

  • Proportion of participants with optimal Glycated haemoglobin Level (HbA1c Level) of 7% or lower

    6 months

  • Proportion of participants with optimal Systolic and Diastolic Blood Pressure

    6 months

  • +3 more secondary outcomes

Study Arms (4)

SCOPE-DM only

EXPERIMENTAL

Participation in SCOPE-DM programme without supply of glucometers and accessories

Behavioral: SCOPE-DM

SCOPE-DM with 3 months' supply of glucometer

ACTIVE COMPARATOR

Participation in SCOPE-DM programme with 3 months' supply of glucometers and accessories

Behavioral: SCOPE-DM with 3 months' supply of glucometer

SCOPE-DM with 6 months' supply of glucometer

ACTIVE COMPARATOR

Participation in SCOPE-DM programme with 6 months' supply of glucometers and accessories.

Behavioral: SCOPE-DM with 6 months' supply of glucometer

Control

NO INTERVENTION

Usual care by healthcare provider/ clinics of Tsao Foundation without participation in SCOPE-DM programme

Interventions

SCOPE-DMBEHAVIORAL

The 12-week programme aims to support motivation and enable capability for managing diabetes. To this end, the sessions will integrate the knowledge and practical skills components offered in traditional diabetes education with psychological techniques and principles for behavioural change: problem solving, goal-setting and monitoring. The programme offers the potential for older people to learn about their condition and treatment in a psychologically-motivating and confidence-enhancing structure - as such the emphasis is on empowering individuals to make choices and lifestyle changes in line with treatment recommendations through the use of problem solving, goal setting and feedback, and not just on knowledge transfer which has not been shown to be successful in behavioural change. The content and delivery format will largely be informed by motivational interviewing

SCOPE-DM only

Participants in this arm will participate in the SCOPE-DM programme and use the glucometer for 3 months.

SCOPE-DM with 3 months' supply of glucometer

Participants in this arm will participate the in SCOPE-DM programme and use the glucometer for 6 months.

SCOPE-DM with 6 months' supply of glucometer

Eligibility Criteria

Age55 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals with type 2 diabetes mellitus
  • Aged 55 to 99 years old (both inclusive)
  • Community-dwelling

You may not qualify if:

  • Individuals with Type 1 diabetes mellitus
  • Unable to communicate independently in English or Mandarin
  • Mentally incapacitated individuals

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Whampoa Community Club

Singapore, Singapore

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

March 14, 2019

First Posted

March 26, 2019

Study Start

February 26, 2019

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

September 28, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations